Published in BMC Med Res Methodol on July 04, 2007
Systematic reviews of genetic association studies. Human Genome Epidemiology Network. PLoS Med (2009) 1.60
Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies. PLoS One (2009) 1.43
Toward modernizing the systematic review pipeline in genetics: efficient updating via data mining. Genet Med (2012) 1.04
Network integration and graph analysis in mammalian molecular systems biology. IET Syst Biol (2008) 1.03
Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention. Am J Clin Nutr (2009) 0.90
A literature search tool for intelligent extraction of disease-associated genes. J Am Med Inform Assoc (2013) 0.79
Registered access: a 'Triple-A' approach. Eur J Hum Genet (2016) 0.77
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res (2005) 30.44
Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet (2003) 16.51
Replication validity of genetic association studies. Nat Genet (2001) 16.30
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet (2007) 12.13
The genetic association database. Nat Genet (2004) 11.29
Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res (2002) 9.50
Online Mendelian Inheritance in Man (OMIM). Hum Mutat (2000) 7.54
PharmGKB: the Pharmacogenetics Knowledge Base. Nucleic Acids Res (2002) 6.40
The Molecular Biology Database Collection: 2005 update. Nucleic Acids Res (2005) 3.25
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Cytokine gene polymorphism in human disease: on-line databases. Genes Immun (1999) 2.86
Genatlas database, genes and development defects. C R Acad Sci III (1998) 2.80
Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol (2002) 2.56
Development of the Cochrane Collaboration's CENTRAL Register of controlled clinical trials. Eval Health Prof (2002) 2.48
Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. Am J Epidemiol (2006) 2.34
Analysis of genomic and proteomic data using advanced literature mining. J Proteome Res (2003) 2.16
Application of genome-wide single nucleotide polymorphism typing: simple association and beyond. PLoS Genet (2006) 2.02
Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun (2001) 1.94
Genomics and the prevention and control of common chronic diseases: emerging priorities for public health action. Prev Chronic Dis (2005) 1.84
The human obesity gene map: the 2004 update. Obes Res (2005) 1.64
Editorial: Journal of negative results in biomedicine. J Negat Results Biomed (2002) 1.58
T1DBase, a community web-based resource for type 1 diabetes research. Nucleic Acids Res (2005) 1.44
A network of investigator networks in human genome epidemiology. Am J Epidemiol (2005) 1.43
The human obesity gene map: the 2003 update. Obes Res (2004) 1.36
The human obesity gene map: the 2001 update. Obes Res (2002) 1.32
Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun (2002) 1.31
INFEVERS: the Registry for FMF and hereditary inflammatory disorders mutations. Nucleic Acids Res (2003) 1.26
Publication bias is a scientific problem with adverse ethical outcomes: the case for a section for null results. Cancer Epidemiol Biomarkers Prev (2000) 1.20
The human obesity gene map: the 1999 update. Obes Res (2000) 1.13
Current status of the Asthma and Allergy Database. Nucleic Acids Res (1999) 1.12
The human obesity gene map: the 2002 update. Obes Res (2003) 1.08
The human genome project is complete. How do we develop a handle for the pump? Am J Epidemiol (2003) 1.07
The human obesity gene map: the 2000 update. Obes Res (2001) 0.91
An Internet linkage and mutation database for the complex phenotype asthma. Bioinformatics (1998) 0.84
How should meta-regression analyses be undertaken and interpreted? Stat Med (2002) 8.96
Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol (2007) 7.00
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol (2007) 4.96
Evaluation of networks of randomized trials. Stat Methods Med Res (2007) 4.70
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med (2008) 4.34
Interpretation of random effects meta-analyses. BMJ (2011) 4.32
Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol (2002) 4.30
Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data. Ann Intern Med (2013) 4.02
Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ (2006) 3.47
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials (2005) 3.19
Recent developments in meta-analysis. Stat Med (2008) 2.97
Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet (2006) 2.72
Graphical tools for network meta-analysis in STATA. PLoS One (2013) 2.66
Synthesizing evidence on complex interventions: how meta-analytical, qualitative, and mixed-method approaches can contribute. J Clin Epidemiol (2013) 2.59
Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol (2009) 2.45
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med (2009) 2.39
A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. J Clin Epidemiol (2009) 2.26
Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer (2005) 2.16
Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol (2009) 2.15
Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit? Lancet (2005) 2.09
Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects. Genet Med (2009) 2.09
Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis. BMC Med Res Methodol (2011) 1.97
Conceptual and technical challenges in network meta-analysis. Ann Intern Med (2013) 1.92
STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. Eur J Clin Invest (2009) 1.82
Evaluation of inconsistency in networks of interventions. Int J Epidemiol (2013) 1.72
Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med (2005) 1.71
Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am J Epidemiol (2008) 1.71
Assessing the impact of drinking water and sanitation on diarrhoeal disease in low- and middle-income settings: systematic review and meta-regression. Trop Med Int Health (2014) 1.64
Hygiene and health: systematic review of handwashing practices worldwide and update of health effects. Trop Med Int Health (2014) 1.63
The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology (2007) 1.61
Systematic reviews of genetic association studies. Human Genome Epidemiology Network. PLoS Med (2009) 1.60
The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol (2010) 1.49
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet (2009) 1.47
A network of investigator networks in human genome epidemiology. Am J Epidemiol (2005) 1.43
Lack of evidence for the efficacy of memantine in mild Alzheimer disease. Arch Neurol (2011) 1.42
Biases in Randomized Trials: A Conversation Between Trialists and Epidemiologists. Epidemiology (2017) 1.38
Portion, package or tableware size for changing selection and consumption of food, alcohol and tobacco. Cochrane Database Syst Rev (2015) 1.37
Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation. Syst Rev (2014) 1.36
Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med (2006) 1.35
The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PLoS One (2013) 1.32
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol (2009) 1.25
Estimating within-study covariances in multivariate meta-analysis with multiple outcomes. Stat Med (2012) 1.23
A design-by-treatment interaction model for network meta-analysis with random inconsistency effects. Stat Med (2014) 1.21
STrengthening the REporting of Genetic Association Studies (STREGA)--an extension of the STROBE statement. Genet Epidemiol (2009) 1.13
STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE Statement. Ann Intern Med (2009) 1.11
Allowing for uncertainty due to missing data in meta-analysis--part 1: two-stage methods. Stat Med (2008) 1.10
Challenges in the use of literature-based meta-analysis to examine gene-environment interactions. Am J Epidemiol (2010) 1.10
Bayesian meta-analysis and meta-regression for gene-disease associations and deviations from Hardy-Weinberg equilibrium. Stat Med (2007) 1.09
Bayesian multivariate meta-analysis with multiple outcomes. Stat Med (2013) 1.08
Planning future studies based on the conditional power of a meta-analysis. Stat Med (2012) 1.05
Graphical augmentations to the funnel plot assess the impact of additional evidence on a meta-analysis. J Clin Epidemiol (2012) 1.01
Turning the pump handle: evolving methods for integrating the evidence on gene-disease association. Am J Epidemiol (2007) 1.01
Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis. Stat Med (2014) 0.98
Systematic review of controlled trials on the effectiveness of fluoride gels for the prevention of dental caries in children. J Dent Educ (2003) 0.97
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer. Cochrane Database Syst Rev (2015) 0.96
Response to paper by Lang A, Edwards N, and Fleiszer A. J Clin Epidemiol (2007) 0.95
Meta-analysis and subgroups. Prev Sci (2013) 0.95
Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study. BMJ (2009) 0.93
Meta-analysis of genetic association studies under different inheritance models using data reported as merged genotypes. Stat Med (2008) 0.91
Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study. BMJ (2011) 0.90
Allowing for uncertainty due to missing data in meta-analysis--part 2: hierarchical models. Stat Med (2008) 0.90
Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta-analysis. Stat Med (2014) 0.88
Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis. BMC Res Notes (2012) 0.86
Summarising and validating test accuracy results across multiple studies for use in clinical practice. Stat Med (2015) 0.85
Comments on 'Empirical vs natural weighting in random effects meta-analysis'. Stat Med (2010) 0.83
Cognitive-behavioural interventions for children who have been sexually abused. Cochrane Database Syst Rev (2012) 0.83
Meta-analysis in occupational epidemiology: a review of practice. Occup Med (Lond) (2004) 0.82
Characteristics of a loop of evidence that affect detection and estimation of inconsistency: a simulation study. BMC Med Res Methodol (2014) 0.82
Relative efficacy of differential methods of dietary advice: a systematic review. Am J Clin Nutr (2003) 0.82
Two-stage meta-analysis of survival data from individual participants using percentile ratios. Stat Med (2012) 0.80
The impact of trial characteristics on premature discontinuation of antipsychotics in schizophrenia. Eur Neuropsychopharmacol (2013) 0.80
WITHDRAWN: Opioids for the palliation of breathlessness in advanced disease and terminal illness. Cochrane Database Syst Rev (2012) 0.80
Bayesian synthesis of epidemiological evidence with different combinations of exposure groups: application to a gene-gene-environment interaction. Stat Med (2006) 0.79
Linear inference for mixed treatment comparison meta-analysis: a two-stage approach. Res Synth Methods (2012) 0.77
Assessment of systematic effects of methodological characteristics on candidate genetic associations. Hum Genet (2012) 0.77
The association between proximity to animal-feeding operations and community health: a protocol for updating a systematic review. Syst Rev (2014) 0.76
Making the best use of available evidence: the case of new generation antidepressants: a response to: are all antidepressants equal? Evid Based Ment Health (2009) 0.75
Health-related lifestyle in adults and children with primary immune thrombocytopenia (ITP). Br J Haematol (2010) 0.75
Association Between Risk-of-Bias Assessments and Results of Randomized Trials in Cochrane Reviews: the ROBES Meta-Epidemiologic Study. Am J Epidemiol (2017) 0.75